Elevated pretreatment levels of LDH and GGT were prognostic for shorter OS in patients with mUM; low albumin, elevated LDH and ALT for shorter TTCS.

Diagnostic evaluation should follow principle of 'as low as reasonably achievable'; systemic therapy should be deferred until second trimester.

Researchers sought to determine whether zanubrutinib combined with rituximab and lenalidomide would improve remission rates in older adults with newly diagnosed DLBCL.

Gathering first-degree family histories for patients with childhood cancers through currently available questions and a personal history is sufficient to ...

In this study from ASCO GI 2026, researchers presented a 4-year follow-up of the phase 3 CheckMate 9DW trial of nivolumab plus ipilimumab in treatment-naïve HCC.